Skip to main content

Table 2 Correlation between the − 9G polymorphism and clinicopathological parameters of the patients,

From: Novel bone morphogenetic protein 15 (BMP15) gene variants implicated in premature ovarian insufficiency

Clinical Indicators

-9G Polymorphism

P

chi-square

Yes (%)

No (%)

Age at menopause (yrs.)

.47

0.50

 <30

3 (42.9)

10 (58.8)

 ≥30

4 (57.1)

7 (41.2)

Age at menarche (yrs.)

.56

0.33

 <13

5 (71.4)

10 (58.8)

 ≥13

2 (28.6)

7 (41.2)

FSH levels (mIU/ml)

.02

4.88

 <40

3 (42.9)

1 (5.9)

 ≥40

4 (57.1)

16 (94.1)

AMH levels (ng/ml)

.07

3.26

 <.02

3 (50)

10 (76.9)

 ≥.02

3 (50)

3(23.1)

Sonographic findings

.61

0.25

 Normal Ovaries

1 (14.3)

4 (23.5)

 Atrophic Ovaries

6 (85.7)

13 (76.5)